These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20164301)

  • 1. Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.
    Nimitvilai S; Brodie MS
    J Pharmacol Exp Ther; 2010 May; 333(2):555-63. PubMed ID: 20164301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.
    Nimitvilai S; Herman M; You C; Arora DS; McElvain MA; Roberto M; Brodie MS
    Neuropharmacology; 2014 Jul; 82():28-40. PubMed ID: 24657149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of dopamine D2 agonist-induced inhibition of ventral tegmental area neurons by Gq-linked neurotransmitters is dependent on protein kinase C, G protein-coupled receptor kinase, and dynamin.
    Nimitvilai S; McElvain MA; Brodie MS
    J Pharmacol Exp Ther; 2013 Jan; 344(1):253-63. PubMed ID: 23019137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors.
    Nimitvilai S; Arora DS; McElvain MA; Brodie MS
    Neuroscience; 2012 Dec; 226():29-39. PubMed ID: 22986166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol blocks the reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.
    Nimitvilai S; Arora DS; McElvain MA; Brodie MS
    Alcohol Clin Exp Res; 2012 Nov; 36(11):1913-21. PubMed ID: 22551160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C.
    Nimitvilai S; Arora DS; Brodie MS
    Neuropsychopharmacology; 2012 Jan; 37(2):543-56. PubMed ID: 21976045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q).
    Nimitvilai S; McElvain MA; Arora DS; Brodie MS
    J Neurophysiol; 2012 Jul; 108(1):263-74. PubMed ID: 22490559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization.
    Henry DJ; Hu XT; White FJ
    Psychopharmacology (Berl); 1998 Nov; 140(2):233-42. PubMed ID: 9860115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased mesolimbic dopaminergic signaling underlies the waning of maternal caregiving across the postpartum period in rats.
    Grieb ZA; Vitale EM; Morrell JI; Lonstein JS; Pereira M
    Psychopharmacology (Berl); 2020 Apr; 237(4):1107-1119. PubMed ID: 31927604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
    Stittsworth JD; Mueller AL
    Neuropharmacology; 1990 Feb; 29(2):119-27. PubMed ID: 2184375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
    Zhao Y; Kerscher N; Eysel U; Funke K
    J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA).
    Rahman S; McBride WJ
    J Neurochem; 2001 Jun; 77(5):1248-55. PubMed ID: 11389175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors.
    Frye CA; Walf AA; Sumida K
    Pharmacol Biochem Behav; 2004 Jul; 78(3):405-18. PubMed ID: 15251249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dopamine receptors in the ventral tegmental area in conditioned fear.
    de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2009 May; 199(2):271-7. PubMed ID: 19111792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.